{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:25:59Z","timestamp":1792985159672,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0201-x","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T16:44:05Z","timestamp":1418143445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy"],"prefix":"10.1186","volume":"9","author":[{"given":"Ilya","family":"Chumakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Milet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00ebl","family":"Primas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Boucard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Graudens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Laffaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Foucquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Glibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Armin","family":"Nave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Sereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serguei","family":"Nabirotchkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-010-0158-7","volume":"11","author":"A Patzk\u00f3","year":"2011","unstructured":"Patzk\u00f3 A, Shy ME: Update on Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep. 2011, 11: 78-88. 10.1007\/s11910-010-0158-7.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"201_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nrneurol.2013.179","volume":"9","author":"AM Rossor","year":"2013","unstructured":"Rossor AM, Polke JM, Houlden H, Reilly MM: Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol. 2013, 9: 562-571. 10.1038\/nrneurol.2013.179.","journal-title":"Nat Rev Neurol"},{"key":"201_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nm.3664","volume":"20","author":"R Fledrich","year":"2014","unstructured":"Fledrich R, Stassart RM, Klink A, Rasch LM, Prukop T, Haag L, Czesnik D, Kungl T, Abdelaal TAM, Keric N, Stadelmann C, Br\u00fcck W, Nave K-A, Sereda MW: Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nat Med. 2014, 20: 1055-1061. 10.1038\/nm.3664.","journal-title":"Nat Med"},{"key":"201_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.neuro.30.051606.094309","volume":"31","author":"K-A Nave","year":"2008","unstructured":"Nave K-A, Trapp BD: Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci. 2008, 31: 535-561. 10.1146\/annurev.neuro.30.051606.094309.","journal-title":"Annu Rev Neurosci"},{"key":"201_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0896-6273(00)80128-2","volume":"16","author":"M Sereda","year":"1996","unstructured":"Sereda M, Griffiths I, P\u00fchlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA: A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 1996, 16: 1049-1060. 10.1016\/S0896-6273(00)80128-2.","journal-title":"Neuron"},{"key":"201_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1126\/science.1076595","volume":"298","author":"JM Cosgaya","year":"2002","unstructured":"Cosgaya JM, Chan JR, Shooter EM: The neurotrophin receptor p75NTR as a positive modulator of myelination. Science. 2002, 298: 1245-1248. 10.1126\/science.1076595.","journal-title":"Science"},{"key":"201_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nbd.2008.06.015","volume":"32","author":"S Rangaraju","year":"2008","unstructured":"Rangaraju S, Madorsky I, Pileggi JG, Kamal A, Notterpek L: Pharmacological induction of the heat shock response improves myelination in a neuropathic model. Neurobiol Dis. 2008, 32: 105-115. 10.1016\/j.nbd.2008.06.015.","journal-title":"Neurobiol Dis"},{"key":"201_CR8","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.yexcr.2011.07.002","volume":"317","author":"N Callizot","year":"2011","unstructured":"Callizot N, Combes M, Steinschneider R, Poindron P: A new long term in vitro model of myelination. Exp Cell Res. 2011, 317: 2374-2383. 10.1016\/j.yexcr.2011.07.002.","journal-title":"Exp Cell Res"},{"key":"201_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/nm957","volume":"9","author":"MW Sereda","year":"2003","unstructured":"Sereda MW, Meyer zu H\u00f6rste G, Suter U, Uzma N, Nave K-A: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003, 9: 1533-1537. 10.1038\/nm957.","journal-title":"Nat Med"},{"key":"201_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/hep.510230425","volume":"23","author":"H Tashiro","year":"1996","unstructured":"Tashiro H, Fukuda Y, Kimura A, Hoshino S, Ito H, Dohi K: Assessment of microchimerism in rat liver transplantation by polymerase chain reaction. Hepatology. 1996, 23: 828-834. 10.1002\/hep.510230425.","journal-title":"Hepatology"},{"key":"201_CR11","doi-asserted-by":"publisher","first-page":"e98856","DOI":"10.1371\/journal.pone.0098856","volume":"9","author":"JA Hirst","year":"2014","unstructured":"Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, Heneghan C: The need for randomization in animal trials: an overview of systematic reviews. PLoS One. 2014, 9: e98856-10.1371\/journal.pone.0098856.","journal-title":"PLoS One"},{"key":"201_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.72351","volume":"1","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010, 1: 94-99. 10.4103\/0976-500X.72351.","journal-title":"J Pharmacol Pharmacother"},{"key":"201_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ana.21026","volume":"61","author":"G Meyer Zu Horste","year":"2007","unstructured":"Meyer Zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave K-A, Sereda MW: Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol. 2007, 61: 61-72. 10.1002\/ana.21026.","journal-title":"Ann Neurol"},{"key":"201_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","volume":"47","author":"AS Rivlin","year":"1977","unstructured":"Rivlin AS, Tator CH: Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977, 47: 577-581. 10.3171\/jns.1977.47.4.0577.","journal-title":"J Neurosurg"},{"key":"201_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejphar.2007.02.041","volume":"565","author":"BK Beyreuther","year":"2007","unstructured":"Beyreuther BK, Callizot N, Brot MD, Feldman R, Bain SC, St\u00f6hr T: Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur J Pharmacol. 2007, 565: 98-104. 10.1016\/j.ejphar.2007.02.041.","journal-title":"Eur J Pharmacol"},{"key":"201_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.physbeh.2011.05.015","volume":"104","author":"P T\u00e9treault","year":"2011","unstructured":"T\u00e9treault P, Dansereau M-A, Dor\u00e9-Savard L, Beaudet N, Sarret P: Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats. Physiol Behav. 2011, 104: 495-502. 10.1016\/j.physbeh.2011.05.015.","journal-title":"Physiol Behav"},{"key":"201_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1124\/jpet.107.123000","volume":"322","author":"T Bordet","year":"2007","unstructured":"Bordet T, Buisson B, Michaud M, Drouot C, Gale P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacape J, Massaad C, Schumacher M, Steidl E, Maux D, Delaage M, Henderson CE, Pruss RM: Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther. 2007, 322: 709-720. 10.1124\/jpet.107.123000.","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/00031305.1990.10475752","volume":"44","author":"C Markowski","year":"1990","unstructured":"Markowski C, Markowski E: Conditions for the effectiveness of a preliminary test of variance. Am Stat. 1990, 44: 322-326.","journal-title":"Am Stat"},{"key":"201_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1037\/0033-2909.111.2.352","volume":"111","author":"SS Sawilowsky","year":"1992","unstructured":"Sawilowsky SS, Blair RC: A more realistic look at the robustness and Type II error properties of the t test to departures from population normality. Psychol Bull. 1992, 111: 352-360. 10.1037\/0033-2909.111.2.352.","journal-title":"Psychol Bull"},{"key":"201_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1124\/jpet.104.067264","volume":"310","author":"Y Grabovsky","year":"2004","unstructured":"Grabovsky Y, Tallarida RJ: Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther. 2004, 310: 981-986. 10.1124\/jpet.104.067264.","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T-C Chou","year":"2006","unstructured":"Chou T-C: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006, 58: 621-681. 10.1124\/pr.58.3.10.","journal-title":"Pharmacol Rev"},{"key":"201_CR22","first-page":"E237","volume":"304","author":"N Geary","year":"2013","unstructured":"Geary N: Understanding synergy. Am J Physiol Metab. 2013, 304: E237-E253.","journal-title":"Am J Physiol Metab"},{"key":"201_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.106.104117","volume":"319","author":"RJ Tallarida","year":"2006","unstructured":"Tallarida RJ: An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther. 2006, 319: 1-7. 10.1124\/jpet.106.104117.","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR24","doi-asserted-by":"crossref","first-page":"25795","DOI":"10.1016\/S0021-9258(18)47318-8","volume":"269","author":"U Suter","year":"1994","unstructured":"Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI: Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem. 1994, 269: 25795-25808.","journal-title":"J Biol Chem"},{"key":"201_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0378-1119(00)00116-5","volume":"248","author":"D Sab\u00e9ran-Djoneidi","year":"2000","unstructured":"Sab\u00e9ran-Djoneidi D, Sanguedolce V, Assouline Z, L\u00e9vy N, Passage E, Font\u00e9s M: Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene. 2000, 248: 223-231. 10.1016\/S0378-1119(00)00116-5.","journal-title":"Gene"},{"key":"201_CR26","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1523\/JNEUROSCI.5520-03.2004","volume":"24","author":"T Ogata","year":"2004","unstructured":"Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, Nakamura K, Tanaka S: Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci. 2004, 24: 6724-6732. 10.1523\/JNEUROSCI.5520-03.2004.","journal-title":"J Neurosci"},{"key":"201_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/glia.21144","volume":"59","author":"P Arthur-Farraj","year":"2011","unstructured":"Arthur-Farraj P, Wanek K, Hantke J, Davis CM, Jayakar A, Parkinson DB, Mirsky R, Jessen KR: Mouse schwann cells need both NRG1 and cyclic AMP to myelinate. Glia. 2011, 59: 720-733. 10.1002\/glia.21144.","journal-title":"Glia"},{"key":"201_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tins.2011.11.006","volume":"35","author":"JA Pereira","year":"2012","unstructured":"Pereira JA, Lebrun-Julien F, Suter U: Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci. 2012, 35: 123-134. 10.1016\/j.tins.2011.11.006.","journal-title":"Trends Neurosci"},{"key":"201_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fendo.2011.00103","volume":"2","author":"A Faroni","year":"2011","unstructured":"Faroni A, Magnaghi V: The neurosteroid allopregnanolone modulates specific functions in central and peripheral glial cells. Front Endocrinol (Lausanne). 2011, 2: 103-","journal-title":"Front Endocrinol (Lausanne)"},{"key":"201_CR30","first-page":"68","volume":"6","author":"P Procacci","year":"2012","unstructured":"Procacci P, Ballabio M, Castelnovo LF, Mantovani C, Magnaghi V: GABA-B receptors in the PNS have a role in Schwann cells differentiation?. Front Cell Neurosci. 2012, 6: 68-","journal-title":"Front Cell Neurosci"},{"key":"201_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.conb.2013.06.010","volume":"23","author":"TD Glenn","year":"2013","unstructured":"Glenn TD, Talbot WS: Signals regulating myelination in peripheral nerves and the Schwann cell response to injury. Curr Opin Neurobiol. 2013, 23: 1041-1048. 10.1016\/j.conb.2013.06.010.","journal-title":"Curr Opin Neurobiol"},{"key":"201_CR32","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1046\/j.1460-9568.2000.00237.x","volume":"12","author":"S Towers","year":"2000","unstructured":"Towers S, Princivalle A, Billinton A, Edmunds M, Bettler B, Urban L, Bowery NG: GABA B receptor protein and mRNA distribution in rat spinal cord and dorsal root ganglia. Eur J Neurosci. 2000, 12: 3201-3210. 10.1046\/j.1460-9568.2000.00237.x.","journal-title":"Eur J Neurosci"},{"key":"201_CR33","doi-asserted-by":"publisher","first-page":"e1554","DOI":"10.1371\/journal.pone.0001554","volume":"3","author":"H-Y Wang","year":"2008","unstructured":"Wang H-Y, Frankfurt M, Burns LH: High-affinity naloxone binding to filamin a prevents mu opioid receptor-Gs coupling underlying opioid tolerance and dependence. PLoS One. 2008, 3: e1554-10.1371\/journal.pone.0001554.","journal-title":"PLoS One"},{"key":"201_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0304-3835(96)04119-5","volume":"101","author":"SD Hytrek","year":"1996","unstructured":"Hytrek SD, McLaughlin PJ, Lang CM, Zagon IS: Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone. Cancer Lett. 1996, 101: 159-164. 10.1016\/0304-3835(96)04119-5.","journal-title":"Cancer Lett"},{"key":"201_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-1999-13967","volume":"65","author":"M Zhu","year":"1999","unstructured":"Zhu M, Li RC: Receptor binding activities of Schefflera triterpenoids and oligosaccharides. Planta Med. 1999, 65: 99-103. 10.1055\/s-1999-13967.","journal-title":"Planta Med"},{"key":"201_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1097-2765(00)80064-7","volume":"1","author":"MA Singer","year":"1998","unstructured":"Singer MA, Lindquist S: Multiple effects of trehalose on protein folding in vitro and in vivo. Mol Cell. 1998, 1: 639-648. 10.1016\/S1097-2765(00)80064-7.","journal-title":"Mol Cell"},{"key":"201_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2009.09.007","volume":"491","author":"R Kumar","year":"2009","unstructured":"Kumar R: Role of naturally occurring osmolytes in protein folding and stability. Arch Biochem Biophys. 2009, 491: 1-6. 10.1016\/j.abb.2009.09.007.","journal-title":"Arch Biochem Biophys"},{"key":"201_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1006\/nbdi.1999.0274","volume":"6","author":"L Notterpek","year":"1999","unstructured":"Notterpek L, Ryan MC, Tobler AR, Shooter EM: PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol Dis. 1999, 6: 450-460. 10.1006\/nbdi.1999.0274.","journal-title":"Neurobiol Dis"},{"key":"201_CR39","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1021\/bi301635f","volume":"52","author":"JP Schlebach","year":"2013","unstructured":"Schlebach JP, Peng D, Kroncke BM, Mittendorf KF, Narayan M, Carter BD, Sanders CR: Reversible folding of human peripheral myelin protein 22, a tetraspan membrane protein. Biochemistry. 2013, 52: 3229-3241. 10.1021\/bi301635f.","journal-title":"Biochemistry"},{"key":"201_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.1034","volume":"50","author":"L Nobbio","year":"2001","unstructured":"Nobbio L, Mancardi G, Grandis M, Levi G, Suter U, Nave KA, Windebank AJ, Abbruzzese M, Schenone A: PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. Ann Neurol. 2001, 50: 47-55. 10.1002\/ana.1034.","journal-title":"Ann Neurol"},{"key":"201_CR41","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3: RESEARCH0034-10.1186\/gb-2002-3-7-research0034.","journal-title":"Genome Biol"},{"key":"201_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/brain\/awr322","volume":"135","author":"R Fledrich","year":"2012","unstructured":"Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu H\u00f6rste G, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW: A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain. 2012, 135: 72-87. 10.1093\/brain\/awr322.","journal-title":"Brain"},{"key":"201_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/01.wnl.0000297553.36441.ce","volume":"70","author":"ME Shy","year":"2008","unstructured":"Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP: Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology. 2008, 70: 378-383. 10.1212\/01.wnl.0000297553.36441.ce.","journal-title":"Neurology"},{"key":"201_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/NMM:8:1-2:3","volume":"8","author":"D Pareyson","year":"2006","unstructured":"Pareyson D, Scaioli V, Laur\u00e0 M: Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006, 8: 3-22. 10.1385\/NMM:8:1-2:3.","journal-title":"Neuromolecular Med"},{"key":"201_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ajpath.2013.06.002","volume":"183","author":"R Martini","year":"2013","unstructured":"Martini R, Klein D, Groh J: Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditions. Am J Pathol. 2013, 183: 655-660. 10.1016\/j.ajpath.2013.06.002.","journal-title":"Am J Pathol"},{"key":"201_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.yexcr.2013.11.003","volume":"322","author":"A Castorina","year":"2014","unstructured":"Castorina A, Scuderi S, D\u2019Amico AG, Drago F, D\u2019Agata V: PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1\/VPAC2 receptor-mediated activation of PI3K\/Akt signaling pathways. Exp Cell Res. 2014, 322: 108-121. 10.1016\/j.yexcr.2013.11.003.","journal-title":"Exp Cell Res"},{"key":"201_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jnr.10327","volume":"69","author":"M Hai","year":"2002","unstructured":"Hai M, Muja N, DeVries GH, Quarles RH, Patel PI: Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res. 2002, 69: 497-508. 10.1002\/jnr.10327.","journal-title":"J Neurosci Res"},{"key":"201_CR48","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/brain\/awu071","volume":"137","author":"L Nobbio","year":"2014","unstructured":"Nobbio L, Visigalli D, Radice D, Fiorina E, Solari A, Lauria G, Reilly MM, Santoro L, Schenone A, Pareyson D: PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker. Brain. 2014, 137: 1614-1620. 10.1093\/brain\/awu071.","journal-title":"Brain"},{"key":"201_CR49","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/brain\/awp113","volume":"132","author":"I Katona","year":"2009","unstructured":"Katona I, Wu X, Feely SME, Sottile S, Siskind CE, Miller LJ, Shy ME, Li J: PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain. 2009, 132: 1734-1740. 10.1093\/brain\/awp113.","journal-title":"Brain"},{"key":"201_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J: Clinical development success rates for investigational drugs. Nat Biotechnol. 2014, 32: 40-51. 10.1038\/nbt.2786.","journal-title":"Nat Biotechnol"},{"key":"201_CR51","doi-asserted-by":"crossref","unstructured":"Attarian S, Vallat J-M, Magy L, Funalot B, Gonnaud P-M, Lacour A, P\u00e9r\u00e9on Y, Dubourg O, Pouget J, Micallef J, Franques J, Lef\u00e8vre M-N, Ghorab K, Al-Moussawi M, Tiffreau V, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Walter G, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Gr\u00e8s C, Nabirotchkin S, Guedj M, Chumakov I, et al: An Exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis 2014, 9:199.,","DOI":"10.1186\/s13023-014-0199-0"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0201-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0201-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:11:12Z","timestamp":1717614672000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0201-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0201-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"9 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"201"}}